FGFR1 gene gain was significantly more common in patients with SCC than in those with adenocarcinoma or other histologies (SCC vs non-SCC: 28.3% vs 11.4%, P<0.001,) while no association with gender, smoking status, stage or grade was found (table 2). This evidence concerns the gene FGFR1 and adenocarcinoma.